Share Prices & Company Research

Stockbroking

Puretech Health Plc

Current Price 122.40p Bid 122.00p Ask 123.00p Change 0.49%
Last Updated: 05/12/2025 09:47. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Financial Highlights Year Ended 31/12/2024

Revenue
£4.83m
Operating Profit/Loss
£-136.09m
Dividend yield (%)
n/a
Total dividend for year
$n/a
Dividend cover
n/a
P/E Ratio
9.70
More Financials

Key Personnel

Dr. John LaMattina
Independent Non-Executive Director
Mr Michele Holcomb
Independent Non-Executive Director
Ms Kiran Mazumdar Shaw
Independent Non-Executive Director
Ms Sharon Barber-Lui
Independent Non-Executive Director
Dr. Robert Langer
Non-Executive Director
Mr H. Robert Horvitz
Non-Executive Director

Stock Details

EPIC
PRTCL
ISIN
GB00BY2Z0H74
Shares in Issue
237.39m
Market cap
£290.56m

Analyst Views (1)

Strong Buy
 
100.00%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
122.40p
Bid Price
122.00p
Ask Price
123.00p
Volume
32,692
Change Today
0.60p
% Change Today
0.49%
Open
121.70p
Previous Close
121.80p
Intraday High
123.00p
Intraday Low
121.70p
52 Week High
173.00p
52 Week Low
101.60p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

Income Statement

Year End Date
31 Dec 2024
31 Dec 2023
 
$ (M)
$ (M)
Continuing Operations
Revenue
4.83
3.33
Operating Profit/Loss
-136.09
-146.20
Net Interest
4.77
5.08
Pre-Tax Profit
23.77
-36.10
Profit After Tax from continuing operations
27.78
-66.63
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
27.78
-66.63
Attributable to:
Equity Holders of Parent Company
53.51
-65.70
Minority Interests
-25.73
-0.93
Total Dividend Paid
$n/a
$n/a
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2024
31 Dec 2023
Basic
21.00c
-24.00c
Diluted
21.00c
-24.00c
Adjusted
21.00c
-24.00c
Dividend per Share
$n/a
$n/a

Assets

Year End Date
31 Dec 2024
31 Dec 2023
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
15.13
19.36
Intangible Assets
0.60
0.91
Investment Properties
n/a
n/a
Investments
200.17
325.63
Other Financial Assets
n/a
n/a
Other Non-Current Assets
0.47
0.88
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
1.52
2.38
Cash at Bank & In Hand
280.64
191.08
Current Asset Investments
98.05
136.06
Other Current Assets
6.05
17.68
Other Assets
n/a
n/a
Total Assets
602.64
693.97

Liabilities

Year End Date
31 Dec 2024
31 Dec 2023
 
$ (M)
$ (M)
Current Liabilities
Borrowings
7.69
7.09
Other Current Liabilities
33.70
44.28
Total Current Liabilities
41.39
51.37
Non-Current Liabilities
Borrowings
14.67
18.25
Provisions
n/a
52.46
Other Non-Current Liabilities
138.64
113.66
Total Non-Current Liabilities
153.31
184.37
Other Liabilities
n/a
n/a
Total Liabilities
194.70
235.74

Net Assets

Year End Date
31 Dec 2024
31 Dec 2023
 
$ (M)
$ (M)
Net Assets
407.93
458.23

Capital & Reserves

Year End Date
31 Dec 2024
31 Dec 2023
 
$ (M)
$ (M)
Share Capital
4.86
5.46
Share Premium Account
290.26
290.26
Other Reserves
87.10
84.52
Retained Earnings
32.49
83.82
Shareholders Funds
414.71
464.07
Minority Interests/Other Equity
-6.77
-5.83
Total Equity
407.93
458.23

Dividend History

Dividend Metrics

Year End Date
31 Dec 2024
31 Dec 2023
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.